• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23371 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     HAYES, Inc. Full-field digital mammography for breast cancer screening
2011     NIHR Horizon Scanning Centre (NIHR HSC) Indacaterol/glycopyrronium (QVA-149) for chronic obstructive pulmonary disease
2011     HAYES, Inc. Sublingual immunotherapy for allergic rhinitis
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of non-drug treatment strategies in patients with diabetes mellitus type 2: increase of physical activity - Rapid report]
2011     NIHR Health Technology Assessment programme Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ticagrelor - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2011     The Regional Health Technology Assessment Centre (HTA-centrum) Pulse oximetry (POX) screening for congenital heart defects in newborns
2011     HAYES, Inc. Telerehabilitation after stroke
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cessation of smoking in essential hypertension - Rapid report]
2011     The Regional Health Technology Assessment Centre (HTA-centrum) [Treatment in relapsed multiple myeloma; bortezomib, lenalidomide, thalidomide]
2011     HAYES, Inc. Total ankle replacement
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal for the DMP diabetes mellitus type 2 and extraction of new, relevant recommendations]
2011     NIHR Health Technology Assessment programme Hemiarthroplasty and total hip arthroplasty for treating primary intracapsular fracture of the hip: a systematic review and cost-effectiveness analysis
2011     HAYES, Inc. Lipoprotein-associated phospholipase testing for stroke assessment in adults
2011     HAYES, Inc. Trofile™ HIV tropism assay
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Fact sheet: Screening for gestational diabetes - rapid report]
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to the final report A09-02 (benefit assessment of prasugrel)]
2011     HAYES, Inc. Vision therapy for accommodative and vergence dysfunction
2011     HAYES, Inc. Minimally invasive total hip arthroplasty
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for defined speech and language development disorders in children: Appraisal of the KiSS.2 study]
2011     NIHR Health Technology Assessment programme A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of HPV test in primary screening for cervical cancer]
2011     HAYES, Inc. Nicotine replacement therapy for smoking cessation: nicotine gum and nicotine lozenge
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Boceprevir - Benefit assessment according to 35a Social Code Book V (dossier assessment)]
2011     HAYES, Inc. Nicotine replacement therapy for smoking cessation: nicotine nasal spray and nicotine inhaler
2011     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Ventilation systems in operating rooms a health technology assessment]
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pirfenidone - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2011     HAYES, Inc. Nicotine replacement therapy for smoking cessation: nicotine patch
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal for the DMP module on heart failure and extraction of new, relevant recommendations]
2011     HAYES, Inc. NovoSeven coagulation factor VIIa (recombinant) for prevention and control of bleeding in patients without hemophilia
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Stem cell transplantation for multiple myeloma: assessment of the BMT CTN 0102 study]
2010     NIHR Health Technology Assessment programme A randomised 2x2 trial of community versus hospital pulmonary rehabilitation, followed by telephone or conventional follow-up
2010     NIHR Health Technology Assessment programme Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections.
2010     NIHR Health Technology Assessment programme Virus shedding and environmental deposition of novel A(H1N1) pandemic influenza virus
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Methods to screen for hemoglobin S in blood donors selected for exchange transfusions: a review of the clinical effectiveness and guidelines
2010     National Institute for Health and Care Excellence (NICE) Haemorrhoidal artery ligation. NICE interventional procedures guidance 342
2010     NIHR Health Technology Assessment programme Evaluation of triage methods used to select patients with suspected pandemic influenza for hospital admission: cohort study
2010     HAYES, Inc. Paclitaxel-eluting stents for treatment of coronary artery disease
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimizing the implementation of diagnostic imaging decision support tools: a review of the evidence and guidelines
2010     National Institute for Health and Care Excellence (NICE) Arteriovenous crossing sheathotomy for branch retinal vein occlusion. NICE interventional procedures guidance 334
2010     NIHR Health Technology Assessment programme Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion- adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
2010     HAYES, Inc. Photodynamic therapy for actinic keratosis and squamous cell carcinoma in situ
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Cannabinoids as co-analgesics: review of clinical effectiveness
2010     National Institute for Health and Care Excellence (NICE) Endoscopic submucosal dissection of lower gastrointestinal lesions. NICE interventional procedures guidance 335
2010     NIHR Health Technology Assessment programme Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings
2010     HAYES, Inc. Photodynamic therapy for nonmelanoma skin cancer
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Phosphodiesterase 5 inhibitors: a review of the clinical effectiveness and cost-effectiveness
2010     National Institute for Health and Care Excellence (NICE) Transcatheter endovascular closure of perimembranous ventricular septal defect. NICE interventional procedures guidance 336
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Sperm DNA fragmentation and annexin column use in assisted reproductive treatments]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Negative pressure therapy for patients infected wounds: a review of the clinical and cost-effectiveness evidence and recommendations for use
2010     National Institute for Health and Care Excellence (NICE) Endobronchial ultrasound-guided transbronchial biopsy for peripheral lung lesions. NICE interventional procedures guidance 337
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Gefitinib for the treatment of lung cancer]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Silver dressings for the treatment of patients with infected wounds: a review of clinical and cost-effectiveness
2010     National Institute for Health and Care Excellence (NICE) Surgical correction of hallux valgus using minimal access techniques. NICE interventional procedures guidance 332
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Levonorgestrel-releasing intrauterine device (IUD) for patients with hypermenorrhea]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Patient lifts and transfer equipment: a review of clinical and cost-effectiveness and guidelines
2010     National Institute for Health and Care Excellence (NICE) Therapeutic endoscopic division of epidural adhesions. NICE interventional procedures guidance 333
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of serum-free light chain measurement in monoclonal gammopathy]
2010     Finnish Office for Health Care Technology Assessment (Finohta) [18Fluorodeoxyglucose positron emission tomography in the assessment of patients with potentially curable cancer]
2010     HAYES, Inc. Psychosocial interventions as adjunct treatments for pediatric bipolar disorder
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Chair alarms in residential care and acute care: a review of the clinical effectiveness and safety
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Positron emission tomography (PET): diagnostic usefulness and indications]
2010     HAYES, Inc. Quantitative computed tomography for bone mineral density
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Deep brain stimulation for parkinson's disease and neurological movement disorders: a review of the clinical and cost-effectiveness and guidelines
2010     Institute of Health Economics (IHE) Routine preoperative electrocardiogram and chest x-ray prior to elective surgery in Alberta, Canada
2010     Institute for Clinical and Economic Review (ICER) Atrial fibrillation management options
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of detecting rearrangement of FIP1L1-PDGFRA in patients with primary hypereosinophilic syndrome]
2010     Finnish Office for Health Care Technology Assessment (Finohta) [Mechanical non-invasive cough assist device]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Bupropion for adults with attention deficit hyperactivity disorder: a review of the clinical effectiveness and harms of misuse
2010     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Vision screening of preschool children]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Cx501 for cutaneous lesions associated with recessive dystrophic epidermolysis bullosa
2010     Health Council of the Netherlands Gezondheidsraad (GR) The 'thousand-dollar genome': an ethical exploration
2010     HAYES, Inc. Rotating platform knee arthroplasty
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of periodontal disease in patients with diabetes: a review of clinical and cost-effectiveness
2010     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Multidisciplinary and multisectoral interventions targeting patients with back pain – a health technology assessment]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Dabigatran etexilate (Pradaxa) for secondary prevention of venous thromboembolism (VTE)
2010     Finnish Office for Health Care Technology Assessment (Finohta) [Fluorescence cystoscopy in diagnosis and management of superficial bladder cancer]
2010     Health Services Assessment Collaboration (HSAC) A systematic review of economic evaluations for tobacco control programs
2010     Health Council of the Netherlands Gezondheidsraad (GR) [Prenatal screening for trisomy 13 and 18]
2010     HAYES, Inc. Routine ultrasound examination in low-risk pregnancy
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Drug therapy for prophylactic and post-exposure treatment of H1N1: a review of the comparative clinical and cost-effectiveness
2010     The Swedish Council on Health Technology Assessment (SBU) [Silver-releasing dressings in treating chronic wounds]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Dienogest (Visabelle) for recurrent endometriosis - second or third line
2010     Health Services Assessment Collaboration (HSAC) The effectiveness of non-pharmacological interventions for behavioural and psychological symptom management for people with dementia in residential care settings
2010     HAYES, Inc. Screening, brief intervention, and referral to treatment (sbirt) for illicit drug use
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Lindane and other treatments for lice and scabies: a review of clinical effectiveness and safety
2010     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Autologous fat transfer for cosmetic and reconstructive breast augmentation
2010     NIHR Horizon Scanning Centre (NIHR HSC) Duloxetine (Cymbalta) for chronic somatic pain
2010     Basque Office for Health Technology Assessment (OSTEBA) [Review of the psychological treatment in first psychotic episode]
2010     HAYES, Inc. Sirolimus-analog-eluting stents for treatment of coronary artery disease
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography for epilepsy: clinical effectiveness and guidelines
2010     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Hip protectors in long-term care]
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Detection of high risk human papillomavirus E6 and E7 oncogenes for cervical cancer screening]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Ivabradine (Procoralan) for chronic heart failure
2010     Basque Office for Health Technology Assessment (OSTEBA) [Map on shared resources in HTA and Health Services]
2010     HAYES, Inc. Sirolimus-eluting stents for treatment of coronary artery disease
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Bluetooth-enabled hearing technologies: a review of the clinical and cost-effectiveness
2010     NIHR Health Technology Assessment programme Self monitoring of blood glucose in type 2 diabetes
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Applicability of sentinel-lymph-node detection and biopsy in the treatment of vulval cancer]
2010     NIHR Horizon Scanning Centre (NIHR HSC) Linagliptin (Ondero) for type 2 diabetes mellitus - monotherapy or add-on therapy